Results 161 to 170 of about 1,187,200 (399)

Novel mutation associated with non‐compaction ventricular myocardium: A case report

ESC Heart Failure, EarlyView.
Yan Li, Xi Wang, Saiyong Chen, Chun Wu, Fushi Piao   +4 more
wiley   +1 more source

Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy

European Journal of Heart Failure, EarlyView.
Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy. CVF, left ventricular collagen volume fraction; DCM, dilated cardiomyopathy; EMB, endomyocardial biopsy; LV, left ventricular. Aims The need to perform endomyocardial biopsy (EMB) in patients with non‐ischaemic dilated cardiomyopathies (DCM) is debated ...
Elham Kayvanpour, Farbod Sedaghat‐Hamedani, Daniel Tian Li, Ebe Amr, Ali Amr, Bernd Lahrmann, Alan Lai, Christoph Reich, Chenyang Wang, Esther Herpel, Derliz Mereles, Lutz Frankenstein, Niels Grabe, Hugo A. Katus, Norbert Frey, Benjamin Meder   +15 more
wiley   +1 more source

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

European Journal of Heart Failure, EarlyView.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis, Marianna Adamo, Volker Rudolph, Nicole Karam, Ralph Stephan von Bardeleben, Stefan D. Anker, Victoria Delgado, Jörg Hausleiter, Hannah Kempton, Marco Metra, Michael Böhm, Stephan Baldus   +11 more
wiley   +1 more source

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram [PDF]

, 2004
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Neither the natural history of AF nor its response to therapy are sufficiently predictable by clinical and echocardiographic parameters.
Bollmann, Andreas, Husser, Daniela, Olsson, Bertil, Sornmo, Leif, Stridh, Martin   +4 more
core  

Prolapsed double-canted bipolar left ventricular lead for pacing the left atrium via the coronary sinus: experience in 11 patients [PDF]

, 2011
Seth J. Worley, Douglas C. Gohn
openalex   +1 more source

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

European Journal of Heart Failure, EarlyView.
Heart failure (HF) and atrial fibrillation (AF) are major global health challenges with rising prevalence and significant morbidity, mortality, and healthcare burden. Despite advances in HF management, AF remains a critical comorbidity that worsens outcomes and requires ad hoc treatment strategies, increasing the risk of non‐adherence and side effects.
Mark Luedde, Stefan Agewall, Giuseppe Ambrosio, Antoni Bayes‐Genis, Claudio Borghi, Elisabetta Cerbai, Gheorghe A. Dan, Heinz Drexel, Péter Ferdinandy, Erik Lerkevang Grove, Juan Carlos Kaski, Roland Klingenberg, Joao Morais, William Parker, Mark C. Petrie, Bianca Rocca, Anne Grete Semb, Michele Senni, Christian Sohns, Patrick Sulzgruber, Juan Tamargo, Marco Metra, Michael Böhm, Dobromir Dobrev, Samuel Sossalla   +24 more
wiley   +1 more source

Anatomic variability in coronary arterial distribution with regard to the arterial switch procedure [PDF]

, 2002
Anderson, RH, Baltalarli, A, Cook, A, de Leval, MR, Derrick, G, Massoudy, P, McCarthy, KP, Neudorf, U   +7 more
core   +1 more source

Stable Atrial Sensing on Long-Term Follow Up of VDD Pacemakers [PDF]

, 2006
Background: The hemodynamic advantages of maintaining AV synchrony through AV synchronous pacing are widely known as compared to single chamber pacing.
Aithal, Jairam, Kerkar, Prafulla, Narula, Dhiraj, Shah, Ashok   +3 more
core   +2 more sources

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Main categories of harmful drugs in heart failure. CCB, calcium channel blocker; DPP4i, dipeptidyl peptidase‐4 inhibitor; HER2‐TT, human epidermal growth factor receptor 2‐targeted therapy; NSAID, non‐steroidal anti‐inflammatory drug; TKI, tyrosine kinase inhibitor; TZD, thiazolidinedione; VEGF Inh, vascular endothelial growth factor inhibitor.
Amr Abdin, Johann Bauersachs, Magdy Abdelhamid, Suleman Aktaa, Hussam Al Ghorani, Antonio Bayes‐Genis, Jan Biegus, Michael Böhm, Javed Butler, Nicolas Girerd, Marco Metra, Wilfried Mullens, Hadi Skouri, Muthiah Vaduganathan, Seif El Hadidi, Giuseppe M.C. Rosano, Gianluigi Savarese   +16 more
wiley   +1 more source

Left-bundle branch pacing as bail-out strategy after failed coronary sinus lead placement for cardiac resynchronization: a case report [PDF]

, 2022
Thomas Fink, Thomas Eitz, Christian Sohns, Philipp Sommer, Guram Imnadze   +4 more
openalex   +1 more source